DPIIT recognised startup Government of India
Startup India
Wiesel Pharmaceutical Private Limited - pharma in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹94.92 Lakh
▲ 19% YoY
Net profit · FY 2024
₹1.51 Lakh
Net margin 1.6%
EBITDA · FY 2024
₹2.31 Lakh
EBITDA margin 2.4%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Wiesel Pharmaceutical Private Limited
Data last updated:
Wiesel Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24304UP2018PTC103509. Its GSTIN is 09AACCW1961B1ZI (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Shailesh Kumar Chaudhary and Nitin Kumar Chaudhary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 – 955 Sector – H Jankipuram, Lucknow, Uttar Pradesh, India – 226021.
As per the financials filed for FY 2024, the company reported a revenue of ₹94.92 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Lakh (net margin 1.6%) and EBITDA of ₹2.31 Lakh (EBITDA margin 2.4%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
The company is associated with 1 brand: Wiesel Pharmaceutical.
For more details, the company can be reached via its website wieselpharmaceuticalpvtltd.com.
Company details
CIN U24304UP2018PTC103509
Registration Number 103509
Incorporation Date 23 April 2018
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Wiesel Pharmaceutical
Contact details
Wiesel Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh. Its website is wieselpharmaceuticalpvtltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3 – 955 Sector – H Jankipuram, Lucknow, Uttar Pradesh, India – 226021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Wiesel Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Wiesel Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Wiesel Pharmaceutical operates one associated brand: Wiesel Pharmaceutical. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical marketing and product distribution of tablets and capsules. | wieselpharmaceuticalpvtltd.com |
Business activity
The main business activity of Wiesel Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Wiesel Pharmaceutical Private Limited, buy the company report.
Financials of Wiesel Pharmaceutical Private Limited
FY 2025 filings availableWiesel Pharmaceutical Private Limited reported revenue of ₹94.92 Lakh (up 19% YoY) for FY 2024.
Revenue · FY 2024
₹94.92 Lakh ▲ 19%
Net profit · FY 2024
₹1.51 Lakh margin 1.6%
EBITDA · FY 2024
₹2.31 Lakh margin 2.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 17%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years, including 19% growth in the latest year. EBITDA rose 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.31 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.51 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.4% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wiesel Pharmaceutical Private Limited, buy the company report.
Board of directors of Wiesel Pharmaceutical Private Limited
Wiesel Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shailesh Kumar Chaudhary Also directs: Varsha Infratech Private Limited | Director | 05 Feb 2019 | 7 Years 8 Months | Current |
| Nitin Kumar Chaudhary | Director | 23 Apr 2018 | 8 Years 6 Months | Current |
Auditor
Wiesel Pharmaceutical Private Limited is audited by SHYAM MISHRA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHYAM MISHRA & ASSOCIATES | FY 2021 | 034028N |
Shareholding
The shareholding of Wiesel Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Wiesel Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wiesel Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wiesel Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wiesel Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AACCW1961B1ZI | Uttar Pradesh | Active | 01 Jun 2018 |
To see the full GST registrations and return filing status of Wiesel Pharmaceutical Private Limited, buy the company report.
Recent activity
Wiesel Pharmaceutical Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Dewaker Chaudhary ceased to be Director on 05 Feb 2019.
AGM
Wiesel Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wiesel Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Dewaker Chaudhary ceased to be Director.
Appointed
Shailesh Kumar Chaudhary was appointed as Director.
Appointed
Nitin Kumar Chaudhary was appointed as Director.
Incorporation
23 Apr 2018
Wiesel Pharmaceutical Private Limited was registered on 23 Apr 2018 with Roc Kanpur & aged 8 years 6 months as per MCA records.
Frequently asked questions
Wiesel Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 April 2018 (8+ years old) and is registered under CIN U24304UP2018PTC103509.
Wiesel Pharmaceutical has 2 current directors:
- Shailesh Kumar Chaudhary - Director
- Nitin Kumar Chaudhary - Director
The latest financial statements of Wiesel Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Wiesel Pharmaceutical is 09AACCW1961B1ZI, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Wiesel Pharmaceutical is U24304UP2018PTC103509. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wiesel Pharmaceutical was incorporated on 23 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
Dewaker Chaudhary ceased to be Director on 05 Feb 2019. Shailesh Kumar Chaudhary was appointed as Director on 05 Feb 2019. Nitin Kumar Chaudhary was appointed as Director on 23 Apr 2018.
Yes, Wiesel Pharmaceutical is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Wiesel Pharmaceutical can be reached through the website wieselpharmaceuticalpvtltd.com. Its registered office is in Lucknow, Uttar Pradesh, India.
The registered office of Wiesel Pharmaceutical is at 3 – 955 Sector – H Jankipuram, Lucknow, Uttar Pradesh, India – 226021.